Nightingale Appoints an Experienced Executive to lead its efforts in Quebec and the North American Consumer eHealth Market
17 Januar 2012 - 1:30PM
PR Newswire (Canada)
- The Company hires Mr. Luc Sirois to further strengthen its
presence in Quebec and accelerate its penetration of the
consumer eHealth market MARKHAM, ON, Jan. 17, 2012 /CNW/ -
Nightingale Informatix Corporation "Nightingale" or "Company", an
application service provider (ASP) of electronic medical record
(EMR) software and related services today announced the appointment
of Luc Sirois to the role of Vice President and General Manager for
Quebec, effective immediately. As Vice President and General
Manager, Mr. Sirois will be responsible for building Nightingale's
presence in the Quebec (EMR) market, establishing relationships and
partnerships with leading edge clinics, healthcare providers and
other healthcare technology vendors and for bringing Nightingale's
expertise to the province. Mr. Sirois' appointment follows
Nightingale's December 2011 acquisition of assets related to
Medrium Inc's Practice Management software business, which included
a development team in Quebec City. The Quebec City-based
development team will play a significant role in leading
Nightingale's technology innovation and development plans in Quebec
and across North America. In addition to his leadership position in
Quebec, Mr. Sirois will also take on the role of Vice President of
Consumer eHealth for North America. He will oversee the Company's
further penetration of the growing consumer eHealth market, through
the expansion of Nightingale's Patient Access offering and the
introduction of other patient-centric products and services. A
respected industry veteran, Mr. Sirois has more than 15 years of
experience in the Healthcare IT market, helping organizations
launch innovative technologies. Most recently, he served as
Vice President of Consumer Health at a major Canadian
telecommunication company, where he launched consumer eHealth
offerings and spearheaded other healthcare IT initiatives.
Before his role in the telecommunication industry, Mr. Sirois was
Vice President of Business Development and Chief Operating Officer
at Telesystem and Plexo, where he managed a network of clinics,
medical labs, radiology centres and corporate medical
services. Mr. Sirois was also the co-founder of Resonant
Medical, a leading provider of image-guided radiotherapy equipment
that was sold to Elekta Medical in 2009. Mr. Sirois has an
undergraduate degree from McGill University and an MBA from Harvard
Business School. "We believe Luc's leadership and industry
experience will serve as valuable assets as we continue to
strengthen our foothold in Quebec and work to further penetrate the
consumer eHealth market," said Mr. John Bodolai, Executive Vice
President of Nightingale. "With plans to soon launch our bilingual
EMR, Quebec is an important target market for us. We are
excited about furthering our investment in the province and adding
breadth and depth to our Quebec-based team." "Nightingale is
committed to helping physicians enhance patient healthcare," said
Mr. Sirois. "I am a firm believer that the type of innovation we
are bringing to market will shape, in many ways, the way medical
practices will function in the future. With access to more
than 6,000,000 patients through its existing customer base of
healthcare practitioners, Nightingale is already in an enviable
position to make a real difference in the quality of patient care
and the physician-patient relationship; not only nationally, but in
North-America." The addition of Mr. Sirois to the Nightingale
management team is part of the Company's strategy to leverage its
investments in a bilingual platform across the country. Nightingale
was recently awarded a multimillion dollar contract by the
Association of Ontario Health Centers to deploy a bilingual
platform to 3,500 healthcare providers over a two-year period.
About Nightingale Informatix Corporation (www.nightingalemd.com)
Nightingale is one of the fastest growing health care service and
software companies in North America and is recognized as an
industry leader in Web-based clinician and community based
electronic medical records (EMR) and patient portals the needs of
small primary care practices, multi-physician outpatient clinics,
and large scale regional health organizations and networks. Coupled
with integrated practice management, transcription and revenue
cycle management, Nightingale's comprehensive service offering
allows customers to enhance patient care, increase revenue
opportunities and optimize operations. Nightingale is continuously
innovating and enhancing its services to meet the needs of its
growing and diverse customer base. Nightingale - Healthcare
connected. Forward-Looking Statement This press release contains
"forward-looking statements" respecting the issuance and
cancellation of securities of the Company within the meaning of
applicable Canadian securities legislation. Generally,
forward-looking statements can be identified by the use of
forward-looking terminology such as "plans", "expects" or "does not
expect", "is expected", "budget", "scheduled", "estimates",
"forecasts", "intends", "anticipates" or "does not anticipate", or
"believes", or variations of such words and phrases or state that
certain actions, events or results "may" ,"could", "would", "might"
or "will be taken", "occur" or "be achieved". Forward-looking
statements are subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of
activity, performance or achievements of Nightingale to be
materially different from those expressed or implied by such
forward-looking statements, including but not limited to: risks
related to the speculative nature of the medical software industry,
which is affected by numerous factors beyond Nightingale's control;
the ability of Nightingale to successfully integrate its
acquisitions and any liabilities arising as a result of such
acquisitions, access to capital and agreements with its Lenders;
the existence of present and possible future government regulation;
access to debt or equity financing and agreements with its Lenders;
the significant and increasing competition that exists in the
medical software industry; the early stage of Nightingale's
business; and therefore it is subject to the risks associated with
early stage companies, including uncertainty of revenues, markets
and profitability and the need to raise additional funding. All
material assumptions used in making forward-looking statements are
based on management's knowledge of current business conditions and
expectations of future business conditions and trends. Although
management believes the assumptions used to make such statements
are reasonable at this time, our assumptions may not to be as
anticipated, estimated or intended. Certain material factors or
assumptions applied by management in making forward-looking
statements, include without limitation, factors and assumptions
regarding Nightingale's continued ability to fund its business,
rates of customer defaults, relationships with, and payments to,
lenders, demand for Nightingale's products, as well as
Nightingale's operating cost structure. Although Nightingale has
attempted to identify important factors that could cause actual
results to differ materially from those contained in
forward-looking statements, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements. Nightingale
does not undertake to update any forward-looking statements that
are incorporated by reference herein, except in accordance with
applicable securities laws. Further information on Nightingale
Informatix Corporation is available at www.sedar.com. Neither the
TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release. Nightingale Informatix Corporation CONTACT: Media
InquiriesSharmeen ArafatMarketing
Manager905.307.3617sarafat@nightingalemd.comInvestor
InquiriesKristen Dickson, M.Sc.Equicom, a TMX Group CompanyTel:
416.815.0700 ext. 273kdickson@equicomgroup.com
Copyright
Nightingale Informatix Corporati (TSXV:NGH)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Nightingale Informatix Corporati (TSXV:NGH)
Historical Stock Chart
Von Jul 2023 bis Jul 2024